Literature DB >> 1500744

Early diagnosis of human immunodeficiency virus infection in children less than 6 months of age: comparison of polymerase chain reaction, culture, and plasma antigen capture techniques.

W Borkowsky1, K Krasinski, H Pollack, W Hoover, A Kaul, T Ilmet-Moore.   

Abstract

Three techniques were evaluated for their ability to detect human immunodeficiency virus (HIV) in infants from birth to 6 months of age. Polymerase chain reaction (PCR) and HIV cocultivation were of comparable sensitivity, detecting 90% of all positive specimens. Both techniques found positive results in approximately 5% of samples from seroreverting children. Both assays detected HIV in only half of infected newborns, suggesting that this fraction of children was infected during gestation. Plasma p24 antigen was detected in three-fourths of all samples tested but in only half of infected children during the first 2 months of life and 88% of samples from children during the next 4 months. The specificity of p24 antigen detection was 100%.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500744     DOI: 10.1093/infdis/166.3.616

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Management of the infant born to an HIV-1 infected mother.

Authors:  C Rongkavilit; C D Mitchell; S Nachman
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

Review 2.  Infants born to HIV-1 infected women: lessons from the past decade.

Authors:  A Kaul; S Chandwani
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

3.  Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults.

Authors:  E Lyamuya; U Bredberg-Rådén; J Albert; O Grankvist; V Msangi; C Kagoma; F Mhalu; G Biberfeld
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  Prognostic value of immunological data, in vitro antibody production, and virus culture in vertical infection with HIV-1.

Authors:  M C García Rodriguez; I Bates; I de José; F Hawkins; R Martinez-Zapico; A Ferreira; G Fontán
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

Review 5.  Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee.

Authors:  S Hammer; C Crumpacker; R D'Aquila; B Jackson; J Lathey; D Livnat; P Reichelderfer
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

6.  Ultrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection.

Authors:  Susan A Fiscus; Jeffrey Wiener; Elaine J Abrams; Marc Bulterys; Ada Cachafeiro; Richard A Respess
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

7.  Ontogeny of anti-human immunodeficiency virus (HIV) antibody production in HIV-1-infected infants.

Authors:  H Pollack; M X Zhan; T Ilmet-Moore; K Ajuang-Simbiri; K Krasinski; W Borkowsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load.

Authors:  B Weiser; S Nachman; P Tropper; K H Viscosi; R Grimson; G Baxter; G Fang; C Reyelt; N Hutcheon; H Burger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

9.  Effective use of frozen donor peripheral blood mononuclear cells for human immunodeficiency virus type 1 isolation from vertically infected pediatric patients.

Authors:  M O Paul; S Tetali; S Pahwa
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

10.  Rapid screening for early detection of mother-to-child transmission of human immunodeficiency virus type 1.

Authors:  S Cassol; A Butcher; S Kinard; J Spadoro; T Sy; N Lapointe; S Read; P Gomez; M Fauvel; C Major
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.